JOSEPH W DOUCETTE
Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease BELLEVUE, WA NPI 1003839028
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease WA Acerta Pharma LLC All categories
General Payments — all program years on this page
$1,459.48
- Category: General Payments
- Program years: PY2018–2024
- Record count: 34
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $157.18 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $157.18 | 7 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $35.48 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $34.71 | 1 |
| Merck Sharp & Dohme Corporation | $25.98 | 1 |
| PFIZER INC. | $23.87 | 1 |
| Novo Nordisk AS | $22.26 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $14.88 | 1 |
By program year
Records — PY2024 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1086953459 | Novartis Pharmaceuticals Corporation | $34.71 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1092746958 | Boston Scientific Corporation | $14.88 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1096795322 | Novo Nordisk Inc | $22.26 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104609894 | AstraZeneca Pharmaceuticals LP | $17.78 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105885769 | AstraZeneca Pharmaceuticals LP | $17.70 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1131268241 | PFIZER INC. | $23.87 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1141813273 | Merck Sharp & Dohme LLC | $25.98 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.